Kangbainian Lotion Ameliorates Vulvovaginal Candidiasis in Mice by Inhibiting the Growth of Fluconazole-Resistant Candida albicans and the Dectin-1 Signaling Pathway Activation

Kangbainian Lotion Ameliorates Vulvovaginal Candidiasis in Mice by Inhibiting the Growth of Fluconazole-Resistant Candida albicans and the Dectin-1 Signaling Pathway Activation

Vulvovaginal candidiasis (VVC) is an infectious disease caused by Candida species, which affects millions of women worldwide every year. The resistance to available antifungal drugs for clinical treatment is a growing problem. The treatment of refractory VVC caused by azole-resistant Candida is stil...

Full description

Bibliographic Details
Main Authors:	Zewei Chen, Tengshuo Luo, Fengke Huang, Fuzhen Yang, Wenting Luo, Guanfeng Chen, Mengfei Cao, Fengyun Wang, Jun Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Pharmacology
Subjects:	kangbainian lotion fluconazole-resistant vulvovaginal candidiasis Candida albicans dectin-1 signaling pathway
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.816290/full

Similar Items

Use of fluconazole in women of reproductive age with vulvovaginal candidiasis
by: E. A. Mezhevitinova, et al.
Published: (2018-09-01)

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01)

Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
by: Zahra Vahedpoor, et al.
Published: (2021-09-01)

On the resistant pathogens problem of the recurrent vulvovaginal candidiasis
by: Yu V Dolgo-Saburova, et al.
Published: (2014-02-01)

Single and multiple dose Fluconazole in the treatment of candidia vulvovaginitis: a prospective comparative study
by: Ashrafinia M, et al.
Published: (2007-09-01)

Interspecies differences of candida species causing recurrent vulvovaginal candidiasis in response to fluconazole treatment
by: Siamak Naji, et al.
Published: (2017-07-01)

Changing Trends of Vulvovaginal Candidiasis
by: Doddaiah Vijaya, et al.
Published: (2014-01-01)

Three cases of vulvovaginal candidiasis due to Candida nivariensis
by: Phuong Anh Ton Nu, et al.
Published: (2024-03-01)

Vulvovaginal candidiasis therapy in reproductive age women
by: Т. Г. Романенко, et al.
Published: (2020-10-01)

Modern opportunities for the diagnosis and treatment of vulvovaginal candidiasis (in aid of a practitioner)
by: E. R. Dovletkhanova, et al.
Published: (2019-10-01)

Bacterial Vaginosis and Vulvovaginal Candidiasis Pathophysiologic Interrelationship
by: Jack D. Sobel, et al.
Published: (2024-01-01)

A High Rate of Recurrent Vulvovaginal Candidiasis and Therapeutic Failure of Azole Derivatives Among Iranian Women
by: Amir Arastehfar, et al.
Published: (2021-04-01)

Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action
by: C.I.S. Medeiros, et al.
Published: (2022-08-01)

Vulvovaginal candidiasis: etiology, pathogenesis, diagnosis, treatment
by: N. A. Buralkina, et al.
Published: (2019-08-01)

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Is human dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?
by: Nina zahedi, et al.
Published: (2016-09-01)

The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
by: V. N. Serov, et al.
Published: (2016-12-01)

Comparative Efficacy of 10% Sodium Sulfacetamide Lotion and 1% Clotrimazole Lotion in Treatment of Tinea versicolor
by: F Rad, et al.
Published: (2008-01-01)

Treating (Recurrent) Vulvovaginal Candidiasis with Medical-Grade Honey—Concepts and Practical Considerations
by: Senna J. J. M. van Riel, et al.
Published: (2021-08-01)

Itraconazole Improves Vulvodynia in Fungus Culture-Negative Patients Post Fluconazole Failure
by: Rodger Rothenberger, MD, et al.
Published: (2021-08-01)

Compliance with the Updated BASHH Recurrent Vulvovaginal Candidiasis Guidelines Improves Patient Outcomes
by: Lottie Brown, et al.
Published: (2022-08-01)

Sertaconazole in the treatment of vulvovaginal candidiasis
by: Z. N. Efendieva
Published: (2019-10-01)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
by: Gai Ge, et al.
Published: (2022-07-01)

Deletion of both Dectin-1 and Dectin-2 affects the bacterial but not fungal gut microbiota and susceptibility to colitis in mice
by: Yazhou Wang, et al.
Published: (2022-06-01)

Formulasi dan Evaluasi Lotion Kombinasi Magnesium Oil dan Minyak Biji Kelor (Moringa Seed Oil)
by: Yulyuswarni Yulyuswarni
Published: (2021-04-01)

Rheological Characterization of Body Lotions
by: Yao Ming Long, et al.
Published: (2001-04-01)

Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis
by: Khan A, et al.
Published: (2021-04-01)

Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women
by: Luciene Setsuko Akimoto Gunther, et al.

Differentiated approach to the treatment of various forms of vulvovaginal candidiasis
by: T Yu Pestrikova, et al.
Published: (2014-06-01)

Modern approaches to the treatment of vulvovaginal candidiasis
by: N V Artymuk, et al.
Published: (2015-08-01)

Comparing the effects of shallomin lotion and cryotherapy on treating plane warts
by: Reza Yaaghubi, et al.
Published: (2018-01-01)

Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar
by: Khan M, et al.
Published: (2018-03-01)

Ibrexafungerp for the Treatment of Vulvovaginal Candidiasis: Design, Development and Place in Therapy
by: Phillips NA, et al.
Published: (2023-02-01)

The profile of the expression of the immune response genes in the vagina of women in the complex therapy of recurrent vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-06-01)

Vulvovaginal Candidiasis and its Related Factors in Diabetic Women
by: Ozra Tabatabaei Malazy, et al.
Published: (2007-12-01)

Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
by: Diletta Rosati, et al.
Published: (2020-01-01)

Zinc Plasma Levels in Recurrent Vulvovaginal Candidiasis Patients
by: Deryne Anggia Paramita, et al.
Published: (2017-04-01)

Genetic predisposition to a recurrent course of vulvovaginal candidiasis
by: Sh M Pogosyan, et al.
Published: (2017-08-01)

Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis
by: Ali Zarei Mahmoudabadi, et al.
Published: (2013-03-01)

Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis
by: Efate alsadat shojaei, et al.
Published: (2014-11-01)